Cypress Capital Management (Wyoming)’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-5
| Closed | – | – | 268 |
|
|
2021
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 301 |
|
|
2021
Q3 | $0 | Sell |
5
-76
| -94% | – | ﹤0.01% | 297 |
|
|
2021
Q2 | $1K | Hold |
81
| – | – | ﹤0.01% | 286 |
|
|
2021
Q1 | $2K | Sell |
81
-51,349
| -100% | -$1.27M | ﹤0.01% | 270 |
|
|
2020
Q4 | $1.14M | Buy |
+51,430
| New | +$1.14M | 0.99% | 33 |
|